| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |